http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023277521-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2095a53d5fe2817630a4ecd48818f12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_147cda5d85f4aff7b7efb7ec7e2c7689 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| filingDate | 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492fa8c241c35b47badaed0f4505746b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aa03894c468f51157820c7d9ad24220 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e4fe416111428f61e6fcb8ff1967c35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9aa8b285539faa17d42a83f2655a89a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_069cdb970701b018c2a8ee4632e9c115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7549688e7160bd31f78ba69a5c06ca43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfeb53e14e212c8d8a057718255d1b9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_586c6a6cfeee8f61dbce5dae158e7b00 |
| publicationDate | 2023-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2023277521-A1 |
| titleOfInvention | Veterinary pharmaceutical composition comprising 5-hydroxy-1-methylimidazolidine-2,4-dione compound as active ingredient |
| abstract | The present invention relates to a veterinary pharmaceutical composition comprising a 5-hydroxy-1-methylimidazolidine-2,4-dione compound as an active ingredient and, more specifically, to a composition comprising a 5-hydroxy-1-methylimidazolidine-2,4-dione compound or a pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of an animal renal disease, a method for treating an animal renal disease, using the compound, and a functional feed comprising the compound as an active ingredient for prevention or alleviation of an animal renal disease. When administered to companion animals suffering from a renal disease, such as dogs or cats, the 5-hydroxy-1-methylimidazolidine-2,4-dione compound according to the present invention can effectively alleviate and treat symptoms of the renal disease. Therefore, the present invention provides a novel therapeutic agent for treatment of renal disease in animals, which can effectively treat a renal disease, which is a cause of high mortality in companion animals, and a method for treating a renal disease. |
| priorityDate | 2021-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.